The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.




AMA submission to the TGA advisory committee on medicines scheduling – proposals to downschedule mometasone and to advertise glyceryl trinitrate

29 Jan 2019

The AMA opposes the proposal to downschedule certain dermal-use preparations of mometasone from a medicine only available by prescription to an over-the-counter medicine. The AMA also does not support the proposal to allow glyceryl trinitrate to be advertised directly to the public.

Published: 29 Jan 2019